IHG DIAGNOSTICS LIMITED
Significant control: University Of Bristol (25–50%), Deborah Jane Baker (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Ihg Diagnostics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Ihg Diagnostics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
IHG DIAGNOSTICS LIMITED is an active private limited company (company number 03858631) incorporated on 13 October 1999, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 October 2025, showing net assets of £188k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- University Of Bristol
- owns 25–50% of shares
- Deborah Jane Baker
- owns 25–50% of shares
- Timothy Hastings
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 13 October 199927 yrs ago
- Next accounts due
- 31 July 2027in 280 days
- Confirmation statement due
- 27 October 2027in 368 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £188k | — | — | £188k | — | — | 0 |
| 31 October 2024 | £188k | — | — | £188k | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £188,090 at 31 October 2025
- Current assets below creditors within one yearCurrent ratio 0.0
- Incorporated five or more years agoIncorporated 13 October 1999
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 368 days
- Next accounts duein 280 days
- Accounts period endNet assets £188k · micro accounts
- Accounts period endNet assets £188k · micro accounts
- Incorporated
Similar companies in London
Reminders for IHG DIAGNOSTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.